An experimental Parkinson’s disease drug on its way to AbbVie as part of an $8.7 billion acquisition has met the goals of a pivotal study, setting up the pharmaceutical giant with a drug prospect that ...
Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...
– ALTO-207 (fka CTC-501) is a fixed-dose combination of pramipexole and ondansetron designed to induce rapid antidepressant effects while mitigating dose-limiting adverse events of pramipexole – – ...
HONOLULU — Glovadalen (UCB), an investigational brain-penetrant D1 receptor positive allosteric modulator (D1 PAM), is both safe and effective for patients with advanced Parkinson’s disease (PD), new ...
NEW YORK (Reuters Health) - Two "dopamine agonist" drugs commonly used to treat Parkinson's disease -- pergolide (Permax; Eli Lily) and cabergoline (Dostinex; Pfizer) -- may raise the risk of heart ...
Meanwhile, beta blocker medications tend to reduce REM sleep, which is when most dreaming occurs, but research has found that ...
The neurotransmitter dopamine is part of many necessary body functions, including memory, movement, motivation, and the “reward” system in our brain that’s activated when we experience things like ...
KDKA-AM Radio Pittsburgh on MSN
Women claim their prescription drugs led to risky sexual behavior
Women who were prescribed medication to deal with a neurological disorder that impacts one in 10 Americans have said that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback